---
title: "GPR132"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Genetic Information Analysis for Gene GPR132"
tags: ['GeneticInformation', 'GPR132', 'GeneFunction', 'Mutation', 'RelatedDiseases', 'DrugResponse', 'TherapeuticTarget', 'Research']
---

# Genetic Information Analysis for Gene GPR132

## Gene Information

- **Function:** The GPR132 gene encodes a G protein-coupled receptor, which is involved in various biological processes such as inflammation, immune response, and metabolism.

- **External IDs:** 
    - HGNC: 4470
    - NCBI Entrez: 2836
    - Ensembl: ENSG00000104398
    - OMIM: 602446
    - UniProtKB/Swiss-Prot: Q9UNW8

- **Aliases:** G2A, OA3, P2Y10, BM-ER-GP, C14orf10

## Mutations

- **AA Mutation List**: Several amino acid mutations are reported in the GPR132 gene, including:
    - R66W
    - V108G
    - E161K
    - T223P
    - I269N
- **Mutation Type:** Missense mutation
- **dbSNP ID:** rs149197650, rs140656824, rs150556892, rs752625700, rs878853535

- **Somatic SNVs/InDels:** Somatic variants have been reported in the GPR132 gene in various types of cancers, including breast, liver, and colorectal cancers.
- **dbSNP ID:** rs767219686, rs143106989, rs779054980, rs753478265

## Related Diseases

- Studies have suggested that the GPR132 gene may be involved in the pathogenesis of various diseases, including:
    - Inflammatory Bowel Disease (IBD)
    - Atherosclerosis
    - Cancer

## Treatment and Prognosis

- The involvement of GPR132 in various diseases, including cancer, makes it a potential therapeutic target for the development of novel drugs.
- Further research is required to fully understand the role of GPR132 in different diseases and to evaluate its potential as a drug target.

## Drug Response

- Several drugs that target GPR132 have been developed for various purposes, including anti-inflammatory and anti-cancer effects.
- Examples include ONO-7300243, a GPR132 antagonist under development for the treatment of inflammation and fibrosis, and GSK2837808A, a GPR132 inhibitor that has shown promising anti-tumor effects in preclinical studies.

## References

- Subject: GPR132
- Author: Paruchuri, Sailaja
- DOI links to related papers:
    - [GPR132, an inflammation-associated G protein-coupled receptor]([Click](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002234/))
    - [Emerging Role of GPR132 in the Progression of Various Diseases]([Click](https://www.hindawi.com/journals/jir/2020/5426407/))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**